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Adversity, particularly in early life, can cause illness.
Clues to the responsible mechanisms may lie with
the discovery of molecular signatures of stress,
some of which include alterations to an individual’s
somatic genome. Here, using genome sequences
from 11,670 women, we observed a highly significant
association between a stress-related disease, major
depression, and the amount of mtDNA (p = 9.00 3
1042, odds ratio 1.33 [95% confidence interval
[CI] = 1.29–1.37]) and telomere length (p = 2.84 3
1014, odds ratio 0.85 [95% CI = 0.81–0.89]). While
both telomere length and mtDNA amount were asso-
ciated with adverse life events, conditional regres-
sion analyses showed the molecular changes were
contingent on the depressed state. We tested this
hypothesis with experiments in mice, demonstrating
that stress causes both molecular changes, which
are partly reversible and can be elicited by the admin-
istration of corticosterone. Together, these results
demonstrate that changes in the amount of mtDNA
and telomere length are consequences of stress
and entering a depressed state. These findings iden-
tify increased amounts of mtDNA as a molecular
marker of MD and have important implications for
understanding how stress causes the disease.
INTRODUCTION
Adverse life experiences, particularly those in childhood,
contribute to disease morbidity and mortality [1–7]. There
is considerable interest in understanding the mechanisms
through which they do so, as it remains unclear how illness be-
comes apparent decades after the presumed initiating event.
Long-standing hypotheses include chronic activation of the
hypothalamic-pituitary-adrenal axis [8–10] and alterations of
neuroimmune function [11]. Molecular signatures of stressful
life experiences and their relation to disease are therefore of spe-
cial interest to clarify the causal relationship between signature,
disease, and stress.
Causal associations between stressful life events and early
adversities such as childhood sexual abuse and major depres-
sion (MD) are well documented [12–14], suggesting that molec-
ular signatures of stress may be enriched in sufferers of MD. TheCurChina, Oxford and VCU Experimental Research on Genetic
Epidemiology (CONVERGE) recruited 5,864 women with recur-
rent MD and 5,783 matched controls, from whom low-coverage
genome sequences were obtained together with aggregate
measures of lifetime adversities, including assessments of
childhood sexual abuse [15, 16] and stressful life events
[17, 18]. In CONVERGE, both childhood sexual abuse and
stressful life events are strongly associated with risk for MD.
More severe forms of abuse are more strongly associated with
MD than milder forms, consistent with a causal relationship
[16, 18–20].
We focused on two variable components of the somatic
genome suspected to be associated with adverse life experi-
ences: telomeric DNA and mtDNA. Accelerated shortening of
telomeres, the sequence that caps the ends of chromosomes,
has been associated with stress [21–23], anxiety [24], and MD
[25] (although not all findings have been replicated [26, 27]).
Abnormal mitochondrial morphology and altered metabolic ac-
tivity has been reported in mood disorders [28]. Our aim was to
establish whether telomere length and the amount of mtDNA
represent markers of stress-related illness and to explore how
such molecular signatures might arise.
RESULTS
Shortened Telomeres and Increased mtDNA Are
Associated with Adversity
We first examined the relationship between mean telomere
length and amount of mtDNA with MD. We assessed the mean
length of telomeres (across all chromosomes) from low-
coverage whole-genome sequencing (mean coverage of 1.7X)
of saliva DNA samples of 11,670 subjects (Experimental Proce-
dures). MDwas associated with shorter mean telomere length: in
a logistic regression model, the odds ratio for the contribution of
normalized measure of mean telomere to the risk of MD is 0.85
(95% CI = 0.81–0.89, p = 2.84 3 1014). Figure 1A shows the
normalized distributions of mean telomere sequence length in
cases and controls.
We obtained a mean coverage of 102X for the mitochondrial
genome fromwhich we estimated for each individual the amount
of mtDNA.We observed a highly significant association between
MD and the amount of mtDNA (p = 9.00 3 1042 from logistic
regression). Cases had more mtDNA than controls: the odds ra-
tio for the contribution of normalized amount of mtDNA to the risk
of MD was 1.33 (95% CI = 1.29–1.37). Note that the effect is in
the opposite direction to that observed for telomeric DNA. Fig-
ure 1B shows the distributions of normalized amount of mtDNA
coverage for the cases and controls.rent Biology 25, 1146–1156, May 4, 2015 ª2015 The Authors 1147
Figure 1. Two Molecular Markers of
Depression: Mitochondrial DNA and Telo-
mere Length
Left: Boxplot of normalized measure of mean
telomere length (vertical axis) for cases and con-
trols in the CONVERGE study. Middle: Boxplot
of the normalized amount of mtDNA (vertical axis)
in cases and controls in the CONVERGE study.
Right: Boxplot of the normalized amount of
mtDNA (vertical axis) in cases and controls in
the GENDEP/DECC studies (labeled IOP).We replicated the association between MD and increased
amounts of mtDNA in a European case-control study [29, 30].
In contrast to the CONVERGE sample, the DNA was extracted
from blood, and samples were of both sexes.We obtained quan-
titative PCR (qPCR) measures of mtDNA from 216 individuals
(108 cases and 108 controls, 123 women and 93men). In a logis-
tic model, the odds ratio for the normalized measure of mtDNA’s
contribution to the risk of MD was 1.35 (95% CI = 1.11–2.10,
p = 8.3 3 105; Figure 1C).
We next explored the association in the CONVERGE data be-
tween stressful life events and both mean telomere length and
amount of mtDNA. Telomere length was significantly shorter in
those who had experienced more stressful life events (p =
0.0018, by linear regression) and in those reporting childhood
sexual abuse (p = 0.043, by linear regression) (Table 1). The
amount of mtDNA was significantly correlated with both the total
number of stressful life events (linear regression p = 4.833 104)
and childhood sexual abuse (linear regression p = 3.65 3 105).
The association of bothmolecular markers with childhood sexual
abuse was stronger with increasingly severe abuse (Table 1).
Molecular Changes Are Not Due to Technical or
Biological Artifacts
We explored a number of explanations for the association be-
tween molecular markers and MD (Figures 1, S1, and S2; Tables
1 and S1; Supplemental Experimental Procedures). First, we
considered artifacts arising from incorrectly mapped reads. We
found that the association between amount of mtDNA and MD
could not be explained by contamination or mapping errors:1148 Current Biology 25, 1146–1156, May 4, 2015 ª2015 The Authorsnone of the reads used for assessing the
amount of mtDNA mapped to a set of
all bacterial and plasmid genomes, and
nonemapped to nuclear copies ofmtDNA.
Second, we considered whether the
molecular changes might be due to medi-
cation. We could not explain the telomere
length or mtDNA changes as a result of
cases taking antidepressant medication:
among the MD cases, 975 reported never
having taken any antidepressants. Neither
the amount ofmtDNA nor telomeric length
in these subjects differed significantly
from that assayed in the 4,861 individuals
reporting taking antidepressants (t test
p = 0.96 and p = 0.88, respectively).Third, we considered whether the effects might be explained
by alterations in the cellular composition of the saliva between
cases and controls (see Supplemental Experimental Proce-
dures). Methylation of cytosine residues at cytosine-guanine
(CpG) dinucleotides differs between cell types [31–35] and
thus contains information about the cellular composition of the
tissue from which it was extracted [36–38]. We assessed
methylation in 156 individuals (78 cases and 78 controls),
selected from the extremes of the distribution of amount of
mtDNA, and matched for age and other potential confounds.
The sites assayed are shown in Table S1, and the percentage
of methylation at each CpG site is shown in Figure S1. MD
case-control status remained highly significantly associated
with the amount of mtDNA (t test p value = 5.14 3 1018) and
telomere length (p = 6.833 105) after accounting for the degree
of methylation at each of the sites (Figure S2). Expressed as a
change in effect size using Nagelkerke’s R2 measure, there is
a 6% reduction in the R2 in a model including methylation and
the amount of mtDNA to predict MD and a 9% reduction for
telomere length. From this analysis, we concluded that the
cellular composition of saliva collected from cases differed
slightly from that of controls and explained less than 10% of
the differences in the amount of mtDNA and telomere length
between cases and controls.
Molecular Changes Are Contingent on the Depressed
State
To investigate a causal relationship between stressful life events,
MD, amount of mtDNA, and telomere length, we performed a
Table 1. Relationship between Childhood Sexual Abuse, Telomere Length, and the Amount of Mitochondrial DNA
CSA Type Excess Telomeric DNAa t Valueb p Valuec Excess mtDNAa t Valueb p Valuec Number Casesd Number Controlse Totalf
Non-genital CSA 0.02 0.35 0.73 0.08 1.37 0.169 186 81 267
Genital CSA 0.08 1.27 0.20 0.11 2.02 0.045 240 47 287
Intercourse CSA 0.20 2.45 0.01 0.38 4.67 3.05 3 106 159 17 176
Results for analysis of variance in which different forms of childhood sexual abuse (CSA) predict telomere length and the amount of mtDNA. Non-gen-
ital CSA refers to sexual invitation, sexual kissing, and exposing; genital CSA refers to fondling and sexual touching; and intercourse CSA refers to
attempted or completed intercourse.
aEstimated excess of telomeric or mtDNA over mean telomeric DNA or mtDNA in individuals with no CSA.
bt statistic of tests of hypotheses that underlying excess is zero.
cp value of tests of hypotheses that underlying excess is zero.
dNumber of MD cases.
eNumber of controls.
fNumber of total individuals.series of conditional regression analyses, assuming that stress-
ful life events preceded the onset of MD and the molecular
changes (Supplemental Experimental Procedures). Table 2
shows the counts of individuals categorized by MD disease sta-
tus and number of stressful life events, with the means and SEs
for the amount of mtDNA (Table 2) and telomere length (Table 2)
within each category.
If stressful life events have independent causal effects on
MD and the molecular measures, then the latter should become
independent of MD after conditioning on the number of
stressful events. Table 2 shows this is not the case because
the mean differences in amount of mtDNA and telomere length
between cases and controls, when stratified for the number of
stressful life events, remained highly significant (t tests in third
column of Table 2; mtDNA p values range from 1.25 3 1018 to
0.37; telomere length p values range from 4.23 3 105 to
0.0083).
We next asked whether the effect of stressful life events on
MD is entirely indirect, acting via changes in the amount of
mtDNA or telomere length. We rejected this explanation
because the association between MD and stressful life events
remains highly significant after conditioning on either amount
of mtDNA (p = 5.60 3 1099; see Table S2, i) or telomere
length (p = 2.x10100; Table S3, i) in a logistic regression
model. In contrast, the association between stress and amount
of mtDNA or telomere length disappeared when conditioned
on MD (p = 0.11 Table S4, i, and p = 0.11 Table S5, i, respec-
tively). In other words, the predictive power of stress on
amount of mtDNA and telomere length is mediated through a
history of MD.
These conclusions also hold when the number of stressful
life events is replaced by a history of childhood sexual abuse.
In particular, there was no significant difference in the amount
of mtDNA or telomere length when comparing controls who
reported a history of childhood sexual abuse with those
who did not. Mean values of normalized mtDNA for controls
who reported any form of childhood sexual abuse was
0.136 (SE = 0.007) and 0.095 (SE = 0.001) for no such
history; t test p value = 0.66. Comparable values for telomere
length were 0.168 (SE = 0.0125) and 0.072 (SE = 0.001);
t test p value = 0.27.
These analyses indicate that the molecular markers repre-
sent the current state of illness, regardless of the path by whichCurit is reached, and predict that the most pronounced changes
would be found in subjects currently reporting a severe mood
disorder. Our analyses up to this point used subjects for
whom we did not have a current state measure of mood. We
therefore measured the amount of mtDNA in a separate Chi-
nese case-control cohort of MD [39] where a state measure
of mood was available (the Hamilton rating scale [40]). We
selected 29 cases with scores greater than 25 (very severe)
and 25 controls with scores of less than 5. Despite using
such a small sample, we observed a highly significant differ-
ence (t test p value = 0.0008) and an odds ratio of 2.94 (95%
CI 1.26–6.02), more than twice the odds ratio seen in the
CONVERGE sample (odds ratio = 1.33).
Stress Increases the Amount of mtDNA and Shortens
Telomeres
To gain amechanistic understanding of the relationship between
stress, amount of mtDNA, and telomere length, we undertook a
mouse experiment. Sixteen C57BL/6J mice (eight males and
eight females) were stressed for 4 weeks (for 5 days, a different
stressor was administered: tail suspension, force-swim, foot
shock, restraint, and sleep deprivation, followed by 2 days
rest). After 0, 2, and 4 weeks of stress, amount of mtDNA and
telomere length were assessed by qPCR and compared to
age-matched non-stressed controls (eight males and eight
females).
Consistent with our findings in humans, in mice, stress signif-
icantly increased the amount of mtDNA and decreased telomere
length in saliva and in blood (Figure 2). After 4 weeks of stress,
there was a mean increase in the amount of mtDNA of 210%
compared to the unstressed animals in saliva (t test p =
0.0036) and 240% in blood (t test p = 6.1 3 105). At the same
time, the length of telomeric DNA was reduced 28% in saliva
(t test p = 0.0001) and 30% in blood (t test p = 0.0017) in stressed
mice as compared to non-stressed. There were no significant
differences in the white cell parameters between stressed and
non-stressed animals (all p values > 0.05), indicating that this
result is unlikely to be due to differences in the blood cellular
composition.
After 4 weeks of stress, half of the animals (eight stressed
mice and eight controls) were kept in home cages without any
intervention to model a recovery period of no stress. Molecular
markers were again tested in blood and saliva, and resultsrent Biology 25, 1146–1156, May 4, 2015 ª2015 The Authors 1149
Table 2. Relationship between Stressful Life Events, mtDNA,
Telomere Length, and Major Depression
Difference in Normalized mtDNA Levels in Cases of MD and Controls
per #SLE
#SLE MD Control MD Case
mtDNA Difference t
Statistic, p Value
0 0.132 (0.019),
2,487
0.142 (0.024),
1,689
8.86, 1.25 3 1018
1 0.156 (0.026),
1,432
0.0987 (0.027),
1,441
6.83, 1.01 3 1011
2 0.103 (0.034),
757
0.165 (0.033),
935
5.65, 1.84 3 1008
3 0.068 (0.058),
334
0.085 (0.044),
507
2.12, 0.03
4+ 0.062 (0.067),
221
0.132 (0.040),
666
0.89, 0.37
Difference in Telomere Length in Cases of MD and Controls per #SLE
#SLE MD Control MD Case Telomere Difference
T Statistic, p Value
0 0.078 (0.020),
2,542
0.053 (0.025),
1,722
4.10, 4.23 3 105
1 0.098 (0.026),
1,461
0.048 (0.027),
1,470
3.91, 9.42 3 105
2 0.093(0.035),
780
0.069 (0.032),
952
3.36, 8.05 3 104
3 0.042 (0.053),
342
0.085(0.045),
517
1.82, 0.069
4+ 0.060 (0.060),
229
0.129 (0.038),
677
2.65, 0.0083
For each category of stressful life event (#SLE, ranging from none [0] to
more than four [4+] reported events), Table 2 reports the means and
SEs of the normalizedmtDNA levels (top section of the table) and normal-
ized telomere length measures (bottom section of the table), followed by
the numbers of individuals, for MD cases and controls. The last column
gives the t statistic and p value for the difference between cases and
controls.are shown as week 8 in Figure 2. Four weeks after the discontin-
uation of stress, there were no significant differences between
control animals and those that had been previously exposed to
stress (amount of mtDNA in saliva p = 0.50, in blood p = 0.38;
telomere length in saliva p = 0.85, in blood p = 0.76; all p values
from t tests). These results indicate that the molecular changes
are, at least in part, reversible.
Immediately after the cessation of stress, multiple tissues from
the other 16 animals were assayed for the amount of mtDNA and
telomere length. Figure 3 shows results for four tissues: liver,
muscle, brain (hippocampus), and ovary (ovary was chosen as
we were interested to assess whether the changes might be
transmitted to the next generation). For the amount of mtDNA,
there was a significant increase in liver (p value from t test =
0.005), a significant decrease in muscle (p = 0.014), but no signif-
icant alterations in hippocampus (p = 0.50), and a suggestive
change in ovary (p = 0.086). For telomere length, there was a sig-
nificant 54% reduction in liver (p = 0.03), but no significant
changes in other tissues (muscle p = 0.23, hippocampus
p = 0.59, ovary p = 0.30). These results reveal tissue-specific1150 Current Biology 25, 1146–1156, May 4, 2015 ª2015 The Authorchanges in mtDNA, and possibly in telomere length, as a conse-
quence of stress.
Mitochondrial Function Is Altered in Tissues with
Increased mtDNA
Altering the amount of mtDNA presumably reflects functional
changes in mitochondria, a hypothesis we tested by mea-
suring and comparing the oxidative phosphorylation (OXPHOS)
capacity of mitochondria-enriched fractions from the liver of
stressed and non-stressed mice. Figure 4A shows the mean
values for the change in oxygen concentration over time for
liver mitochondrial preparations taken from eight stressed
and eight control (not stressed) animals. Addition of an equal
amount of ADP (driving force for the electron transport chain
after depletion of residual driving force in the fraction with
excess glutatmate and malate) induced a greater increase in
oxygen consumption in mitochondria from the non-stressed
animals than stressed ones (p = 0.038, from a linear model;
Figure 4B). The complete quenching of OXPHOS upon addi-
tion of electron transport chain inhibitor potassium cyanide in
both stressed and non-stressed mice showed oxygen con-
sumption during the experiment was solely due to OXPHOS.
Results of this experiment showed that OXPHOS efficiency
was reduced in the liver tissue of mice whose amount of
mtDNA had increased in response to stress, suggesting either
an adaptive switch to glycolysis or a compromise in mitochon-
drial function.
Glucocorticoid Administration Reproduces the Effects
of Stress
What might be inducing the molecular changes? We considered
one mechanism: activation of the hypothalamic pituitary adrenal
(HPA) axis [41–48]. We administered corticosterone to eight
C57BL/6J female mice over 4 weeks and oil vehicles of
the same volume to eight control mice of the same strain. Fig-
ures 5 shows that after 4 weeks, there was significantly more
mtDNA in the saliva (p = 0.011) and in the blood (p = 0.0013) of
treated mice compared to controls and that telomere length
had significantly reduced in both tissues (in saliva: p = 0.0023;
in blood: p = 0.0016; all p values from t tests).
DISCUSSION
We report here two important observations on the relationship
between MD and two molecular signatures of adversity, the
amount of mtDNA and mean telomere length. First, the changes
in amount of mtDNA and telomere length are contingent on the
presence of MD. We found no significant molecular changes in
those who reported stressful life events, including childhood
sexual abuse, but had never been depressed. Second, in a
mouse model, while stress over a period of weeks did increase
the amount of mtDNA and shorten telomere length, both
changes were at least partly reversible. While early environ-
mental adversity may result in permanent changes in physiology
and risk of disease [49], our results indicate that it is important to
recognize two trajectories, one leading to molecular signatures
of stress and one to illness.
For the first trajectory leading from adversity to molecular
changes, one possible pathway is through the endocrines
Figure 2. Effect of Chronic Stress onmtDNA
in Saliva and Blood of Mice
Boxplot of relative mtDNA changes and relative
mean telomere length over time inmice exposed to
stress (red) and controls (blue). The vertical axis
shows the amount of DNA, assessed by qPCR,
relative to the mean of the values obtained before
stress was imposed (week 0). The mean of week
0 is set to 1, so that results from subsequent weeks
are fold changes relative to pre-stress levels. The
horizontal axis is time in weeks from the beginning
of the experiment. Stress was discontinued after
week 4, so week 8 shows results for previously
stressed animals after 4 weeks of living in a home
cage. At the 4 week time point, the amount of
mtDNA in blood and saliva was significantly
greater in stressed animals (t test p = 6.1 3 105
and p = 0.0036, respectively). Also at the 4 week
time point, relative mean telomere lengths in
stressed mice were significantly lower in saliva (t
test p = 0.0001) and blood (t test p = 0.0017) as
compared to non-stressed mice. Differences be-
tween stressed and non-stressed mice in both
measures were not significant at the start of the
experiment or at the 8 week time point.system, particularly the activation of the hypothalamic pituitary
axis, since changes in both molecular markers could be
reproduced in mice by administration of corticosterone.
Release of glucocorticoids is known to increase in response
to stress. Severe stressors, such as childhood sexual abuse
[42, 50], alter pituitary-adrenal and autonomic reactivity.
In some circumstances, the consequences may be deleterious
rather than adaptive: glucocorticoids have been implicated
in the pathophysiology of posttraumatic stress disorder
[51, 52], and it has been known for many years that some
patients with MD exhibit hypersecretion of cortisol [41, 53,
54], in part due to corticotrophin releasing factor (CRF) hyper-
secretion [55].
For the second trajectory leading to illness, we hypothesize
that while adversity may on its own have an effect on both
the amount of mtDNA and mean telomere length, the extent
and persistence of these molecular changes depend on an in-
dividual’s susceptibility to MD, either from genetic or additional
environmental predisposing factors. In many individuals, the
molecular signatures will be small and transitory, but in those
with MD, the effects may be larger or last for a longer period
of time. Subjects who have never been diagnosed with MD,
yet suffered severe adversity, may have had detectable alter-
ations in mtDNA levels and mean telomere length in particular
tissues at the time they experienced stressful life events, but
these changes would have reversed and no longer be detect-Current Biology 25, 1146–1able by the time they were interviewed.
We emphasize that the molecular
changes we observe are neither risk fac-
tors nor causes of MD. The correlation
between stress, mtDNA, and telomere
length is contingent upon MD; we could
find no evidence that stressful life eventsact via changes in mtDNA or telomere length to increase the
risk of MD. Thus, our data provide no support for a role of
changes in the amount of mitochondrial DNA or length of telo-
meres in regulating mood.
The disease-state dependence of the measures is important
when considering the potential use of the changes as bio-
markers. It is noteworthy in this regard that in a sample when
we assayed amount of mtDNA in currently severely ill subjects,
a robust difference was detected in a comparison of just 29
cases and 25 controls. This suggests that, despite the relatively
small effects and large variances seen in the saliva sample, there
may be circumstances where the amount of mtDNA could serve
as a useful biomarker. The relatively larger increases seen in
the mouse experiment (up to 4-fold) suggest that controlling
for inter-individual variation would improve the chances of the
biomarkers having a clinical application.
Changes in mean telomere length and levels of mtDNA pre-
sumably reflect altered metabolic strategies in times of
perceived or expected stress. Experiments assessing OXPHOS
efficiency in mice showed a decrease in OXPHOS energy pro-
duction in stressed mice with elevated mtDNA levels. The tis-
sue-specific effects of stress on amount of mtDNA and mean
telomere suggest different, or possibly sequential, pathways
governing tissue-specific change. It is possible that these
changes might in part explain changes in appetite and sleep
occurring during the state of depression.156, May 4, 2015 ª2015 The Authors 1151
Figure 3. Alterations of mtDNA in Different
Tissues after 4 Weeks of Stress
Top: Assessment of mtDNA in four tissues.
Bottom: Assessment of telomere length in four
tissues. The vertical axis shows the amount of
mtDNA or telomere length assessed by qPCR,
relative to the mean of the values obtained for
control animals (no stress). The horizontal axis
gives the names of the tissues for the two condi-
tions: stress (red) and no stress (blue).EXPERIMENTAL PROCEDURES
The CONVERGE Study, Samples, DNA Preparation, and Sequencing
All 11,670 samples are drawn from the CONVERGE study of MD. The study
protocol was approved centrally by the Ethical ReviewBoard of Oxford Univer-
sity (Oxford Tropical Research Ethics Committee) and the ethics committees
responsible for each hospital in China. The study posed minimal risk to the
subjects (an interview and saliva sample). Stressful life events and childhood
sexual abuse were assessed retrospectively. The stressful life events section
of the CONVERGE interviewwas developed for the Virginia Adult Twin Study of
Psychiatric and Use Disorders (VATSPUD) [17]. It assesses 16 traumatic life-
time events and the age at their occurrence. The childhood sexual abuse
was a shortened version of the detailed module used in the VATSPSUD study,
which was in turn based on the instrument developed byMartin et al. [56]. DNA
was extracted from saliva samples using the Oragene protocol.
Sequencing librarieswere constructed fromDNA fragmentedusing theCova-
ris Adaptive Focused Acoustics (AFA) technology. QIAquick Gel Extraction kit
was used to purify the DNA fragments. Each DNA sample was uniquely tagged
with a sequencing index for multiplex library preparation. Insert sizes were on
average 400 bp. Library quality was checked with an Agilent 2100 Bioanalyzer
and ABI StepOnePlus Real-Time PCR System. Libraries were sequenced on
IlluminaHiseq2000machines.Sequencing reads foreachof the11,670samples
were aligned toGenomeReferenceConsortiumHumanBuild 37patch release5
(GRCh37.p5) with Stampy (v.1.0.17) [57] and stored in BAM format [58].
The GENDEP and DeCC Studies, Samples, and qPCR
Cases and control samples were drawn from the United Kingdom Depression
Case-Control (DeCC) study [29] and theGenome-Based Therapeutic Drugs for
Depression (GENDEP) study [30]. mtDNA copy number was estimated from
DNA extracted from blood samples by qPCR, using a TaqMan Universal PCR
MasterMix on anABI StepOnePlusReal-Time PCRSystem (Life Technologies).
The pre-designed TaqMan assay Hs02596867_s1 was used to amplify a frag-1152 Current Biology 25, 1146–1156, May 4, 2015 ª2015 The Authorsment of the MT-CYB gene on the mitochondrial
chromosome in duplex with the TaqMan RNaseP
CopyNumber Reference Assay (Life Technologies,
part number 4403326) as an internal control.
Extracting and Quality Control of
Mitochondrial Reads from Low-Coverage
Whole-Genome Sequencing Data
All reads mapped to the human mitochondrial
genome NC_012920.1 were extracted from the
whole-genome BAM files mapped to GRCh37.p5
using Samtools (v.0.1.18) [58]. The mitochondrial
reads extracted were then converted to the
FASTQ format using Picardtools (v.1.108, http://
broadinstitute.github.io/picard/) and mapped to a
combined reference containing 894 complete bac-
terial genomes, 2,024 complete bacterial chromo-
somes, 154 draft assemblies, and 4,373 complete
plasmids sequences (in total, 7,390 unique bacte-
rial DNA sequences) available on NCBI using BWA
(v.0.5.6) [58]. All reads mapped to bacterial DNA
sequences were filtered out using Samtools(v.0.1.18) [58] by imposing a mapping quality filter of 59 (Phred-scale probabil-
ity of being wrongly mapped) and removing reads with FLAGs (-F 1804) that
identify unmapped reads, unpaired reads, reads that do not pass quality con-
trol, reads thatmay be PCR or optical duplicates, and reads that are secondary
alignments that alsomap to other areas of the reference. No reads from filtered
BAM files of any sample map onto the combined bacterial reference.
Estimation of mtDNA Copy Number
Average read depth per 100 bp is calculated for the mtDNA reads mapped to
NC_012920.1 both before and after filtering out poorly mapped reads
including those potentially from bacterial genomes using SAMTOOLs
(v.0.1.18) [58]. There are regions in the mitochondrial genome replicated in
the nuclear genome commonly known as nuclear copies of mitochondrial
DNA (NUMTs), which would most likely be present as secondary alignments.
We calculated average read depth per segment of 100 bp in the mtDNA align-
ments both before and after filtering and compared the two sets of read
depths. To reduce errors in estimation of coverage due to NUMTs, segments
with big differences in read depth (>5% of the filtered read depth) between the
filtered and unfiltered alignments that are more likely to span NUMTs were
excluded from our calculation of mtDNA copy number. We arrived at a mea-
sure of mtDNA copy number by taking the mean read depth in the filtered
alignments across all remaining 100 bp segments, then regressing it with
sequencing batch, sample age, and average filtered read depth on chromo-
some 20, then transforming the residuals to normality using a quantile normal
function in the R statistical software language [59].
Estimation of Mean Telomere Length
Mean telomere length was quantified from low-coverage whole-genome
sequencing data mapped to Genome Reference Consortium Human Build
37 patch release 5 (GRCh37.p5) with Telseq v.0.0.1 [60]. The estimated
mean telomere length output from Telseq was already corrected for whole-
genome coverage and the GC content of DNA; it was then regressed with
AB
Figure 4. The Oxygen Consumption of
Mouse Liver after Stress Administration
(A) Oxygen concentration (vertical axis) detected
per second (horizontal axis) per mg of mitochondria.
The slope of the curve indicates the rate of oxygen
consumption. Glutamate/malate (GL/MA) is added
at 3min after addition of isolatedmitochondria, and
oxygen consumption was assessed after substrate
addition. The addition of ADP (100 s later) initiates
active respiration while potassium cyanide (KCN)
(100 s later) inhibits all mitochondrial function.
(B) Oxygen consumption rate per mg of mitochon-
dria after the addition of the three compounds,
comparing stressed and non-stressed animals.batch and sample age before the residuals were transformed to normality us-
ing a quantile normal function in the R statistical software language [59].
Association between Molecular Markers, MD, and Stress
We tested for association between MD and molecular markers using logistic
regression in the R statistical software language [59]. All logistic regression
models included as covariates the first three principal components (PCs)
from a principal-component analysis (PCA) performed with Genome-wide
Complex Trait Analysis (GCTA) v.1.24.4 [61] using a genetic relationship matrix
(GRM). The GRM was generated with 561,819 common, tagging single nucle-
otide polymorphisms (SNPs) from all autosomes. All SNPs in this tagging set
were polymorphic in 1,000G phase 1 Asian (ASN) panel, occur at greater
than 5% minor allele frequency in CONVERGE study samples, and are out
of linkage disequilibrium (LD) with each other (maximum pairwise LD = 0.8).
Mouse DNA Extraction
DNA was extracted from mouse tissues using a QIAamp DNA Investigator Kit
(QIAGEN). Saliva was collected from mice by inserting a disposable inocula-
tion loop into the animal’s mouth, allowing the animal to chew for a few sec-
onds, before rinsing the loop in QIAampDNA Investigator Kit ATL buffer. Blood
was collected from a superficial tail vein.
Quantification of mtDNA Levels by qPCR
qPCRwas carried out using the Bio-Rad iQ SYBRGreen supermix supplied by
Roche Molecular Biochemicals. A nuclear genomic fragment of 160 bp was
amplified from the mouse Gapdh gene (forward 50-TGACGTGCCGCCTGGA
GAAAC-30, reverse 50-CCGGCATCGAAGGTGGAAGAG-30. A 117 bp fragment
of the mitochondrial genome (positions 13603–13719) was amplified with
primers described in [62] (forward 50- CCCAGCTACTACCATCATTCAAGT-30,
reverse 50-GATGGTTTGGGAGATTGGTTGATGT-30). qPCR was performed
under the following conditions: denaturation 95C for 10min followed by 50 cy-
cles of 15 s at 95C and 1min at 60C. An estimate of the mtDNA copy number
was calculated using the mean of Gapdh as a control [63]. All samples wereCurrent Biology 25, 1146–1duplicated at each time point. PCR efficiencies
were between 90%–110% (average coefficient
variance: 0.806). PCR runs were discarded if
they failed to meet the following criteria: no
template control (NTC) with a quantitation cycle
(Cq) < 38 cycles; sample with a Cq > 30 cycles;
PCR efficiency > 90% and < 110.0%; standard
curve R2 < 0.980; replicate group Cq SD greater
than 0.20. qPCRs were carried out at the end of
each experiment and all time points were analyzed
on a single plate, thus excluding batch effects.
Quantification of Telomere Length by
Monochrome Multiplex qPCR
Average telomere length was measured from
mouse DNA using a previously described mono-
chrome multiplex qPCR (MMQPCR) method [64]with the following conditions: denaturation at 95C for 15min followed by 2 cy-
cles of 15 s at 94C and 60 s at 49C, 4 cycles of 15 s at 94C and 30 s at 59C,
20 cycles of 15 s at 85C and 30 s at 59C, and 27 cycles of 15 s at 94C, 10 s
at 84C, and 15 s at 85C. Forward and reverse telomeric primers were 50-
ATACCAAGGTTTGGGTTTGGGTTTGGGTTTGGGTTCATGG-30 and 50-GAGG
CAATATCCCTATCCCTATCCCTATCCCTATCCCTAACC-30. Average telo-
mere length ratio was estimated from the ratio of telomere product to that of
a single copy nuclear gene albumin, forward and reverse primers for which
were 50-CGGCGGCGGGCGGCGCGGGCTGGGCGGAAACGCTGCGCAGAA
TCCTTG-30 and 50-GCCCGGCCCGCCGCGCCCGTCCCGCCGCTGAAAAG
TACGGTCGCCTG-30.
Mitochondrial Oxygen Consumption
We measured oxygen consumption from mouse liver mitochondrial prepara-
tions over time using a Clark electrode. After the addition of respiratory sub-
strates (glutamate and malate), oxygen consumption was monitored for 100
s, after which ADPwas added and oxygen consumptionmeasured for a further
100 s. Potassium cyanide (KCN) was added 100 s later to inhibit all mitochon-
drial oxygen consumption.
Animal Experiments
All experiments were carried out in strict accordance with the recommenda-
tions in the Guide for Laboratory Animals Facilities and Care as promulgated
by the Council of Agriculture, Executive Yuan, ROC, Taiwan. The protocol
was approved by the Institutional Animal Care and Use Committee of Chang
Gung University (permit number: CGU13-067). Animals were group housed
and randomly assigned to stress or non-stress experiments.
Mouse stress experiment: mice (strain C57BL/6J, female n = 8, male n = 8,
aged 12 months) were stressed over 5 days followed by 2 days rest, repeated
for 4 weeks. On the first day, animals were suspended from their tails for
10 min. This was repeated three times, with 5 min rest between tail suspen-
sions. On the second day, animals were placed in a cylinder of deep water
from which there was no escape for 10 min. The forced swim was repeated156, May 4, 2015 ª2015 The Authors 1153
Figure 5. Effect of Daily Subcutaneous In-
jection of Corticosterone on mtDNA and
Telomere Length in Saliva and Blood inMice
Boxplot of relative amount of mtDNA and relative
mean telomere length over time in mice injected
with corticosterone (red) and controls injected with
the same volumes of oil vehicle (blue). The vertical
axis shows the amount of mtDNA assessed by
qPCR, relative to the mean of the values obtained
before corticosterone was injected (week 0). The
mean of week 0 is set to 1, so that results from
subsequent weeks are fold changes relative to pre-
stress levels. The horizontal axis is time in weeks
from the beginning of the experiment. After
4 weeks, the amount of mtDNA levels in mice in-
jected with corticosterone was significantly higher
in saliva (t test p = 0.011) and blood (t test p =
0.0013) as compared to mice injected with oil
vehicle; relative mean telomere lengths were
significantly reduced in both tissues (in saliva: t test
p = 0.0023; in blood: t test p = 0.0016) in mice in-
jected with corticosterone as compared to mice
injected with oil vehicle.twice with a 10 min rest. On the third day, a foot shock was administered three
times (0.75 mA for 10 s with 10 s rest). On the fourth day, animals were
restrained in a cylindrical tube (12 cm in length and 3 cm in diameter) for
3 hr. On the fifth day, animals were sleep deprived for 24 hr (mice were put
in water tank, containing multiple and visible platforms [4.5 cm in height and
diameter] surrounded by water for 24 hr). For the glucocorticoid experiment,
mice (strain C57BL/6J, female n = 8, aged 12 months) underwent daily subcu-
taneous injection of 30 mg/kg corticosterone (Sigma) or vehicle (oil) for
28 days. Association between mtDNA, telomere length, and stress was
performed in a linear mixed model using the lme4 package in the statistical
software language R [59]. The null model included only weight. Variation in
the amount of mtDNA between different tissues was assessed by a t test,
comparing values between controls and experimental animals.
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